Zn (Various Forms)
Essential for T-cell development and function. Reduces duration of colds when taken early.
Required for cell division and protein synthesis during tissue repair.
Supports healthy testosterone levels and reproductive function.
Take with food to reduce nausea. Zinc picolinate and gluconate absorb better than oxide. Long-term high doses can interfere with copper absorption.
Zinc Fact Sheet
Not all forms absorb equally — these are ordered best-absorbed first.
Chelated with picolinic acid; among the best-absorbed zinc forms.
Well absorbed with a more neutral taste.
Common in lozenges; decent absorption.
Cheap and common in low-cost products, but poorly absorbed.
Absorption varies between people; informational only, not medical advice.
What the evidence says — with links to the original studies
Zinc is an essential trace mineral with well-established roles in immune function, enzyme catalysis, protein synthesis, and wound healing, and its RDA and Tolerable Upper Intake Level (40 mg/day for adults) are set by authoritative bodies (NIH ODS, EFSA). Evidence that zinc lozenges taken at cold onset shorten cold duration is supported by multiple meta-analyses, but the 2024 Cochrane review rated the evidence low-certainty and inconclusive, so this specific application is best described as promising-but-unsettled within an overall widespread consensus on zinc's essentiality. Bioavailability differs modestly by chemical form (organic salts such as gluconate, citrate, glycinate and picolinate generally absorb better than oxide), though head-to-head human data are limited and heterogeneous. High supplemental doses (>=50 mg/day for weeks) can induce copper deficiency and impair immune function.
RDA 11 mg/day men, 8 mg/day women; UL 40 mg/day for adults. States doses of 50 mg or more over weeks can inhibit copper absorption, reduce immune function, and lower HDL. Notes absorption ~61% for citrate/gluconate vs ~50% for oxide; zinc may reduce cold duration but not severity.
EFSA sets zinc Population Reference Intakes that scale with dietary phytate (300-1200 mg/day): roughly 7.5-12.7 mg/day for women and 9.4-16.3 mg/day for men. Phytate is the key inhibitor of zinc bioavailability.
34 trials. Low-certainty evidence that zinc may reduce cold duration by ~2 days; no clear evidence for preventing colds or reducing severity. Authors call the evidence inconclusive due to heterogeneity in zinc type, dose, and outcome measurement.
Seven RCTs (575 participants): zinc lozenges reduced cold duration by 33% (95% CI 21-45%). Acetate 40% vs gluconate 28% (difference not significant). Doses above ~100 mg/day showed no added benefit.
Pooled 3 double-blind placebo-controlled trials (199 patients). Zinc acetate lozenges (80-92 mg/day) sped recovery, rate ratio 3.1 (95% CI 2.1-4.7); by day 5, 70% of zinc vs 27% of placebo patients recovered (NNT 2.3).
Concludes zinc glycinate and gluconate are better absorbed than other forms; oxide and sulfate rank lower; picolinate evidence mixed. Emphasizes heterogeneous designs and small samples limit definitive rankings.
Counterweight to positive lozenge meta-analyses: rates the cold-duration benefit as low-certainty, finds no prevention benefit. Note an earlier 2011/2013 Cochrane review (Singh & Das) was withdrawn in 2015 over data-integrity concerns.
Educational summary of published research — not medical advice. Consult a qualified professional before supplementing.
Join our collective laboratory. Share your experience level with this topic and help others gauge the journey.
Based on .
No one has shared yet. Be the first to place a pin on the map.
check_circle You marked yourself as .
Status: In Your Stack Status: Not in Stack